Insider Transactions Reported by 16 Insiders of Mineralys Therapeutics, Inc.

Symbol
MLYS on Nasdaq
Location
Radnor, PA

Insiders trading volume in the past year

Mineralys Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Taylor Slingsby Director, 10%+ Owner $271,156,102 -$43,350,000 -14% 19 Feb 2026
Srinivas Akkaraju Director, 10%+ Owner $201,471,033 +$14,999,993 +8% 19 Feb 2026
Samsara BioCapital GP, LLC 10%+ Owner $76,611,366 13 Mar 2025
Jon Congleton Chief Executive Officer, Director $26,740,148 -$10,679,699 -29% 19 Feb 2026
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $19,199,542 14 Feb 2023
David Malcom Rodman Chief Medical Officer $2,214,004 -$13,432,017 -86% 09 Mar 2026
Adam Scott Levy CFO and Secretary $1,663,882 -$7,524,038 -82% 19 Feb 2026
Eric Warren Chief Commercial Officer $1,316,352 04 Mar 2026
Daphne Karydas Director $212,536 -$689,797 -76% 19 Feb 2026
Alexander M. Gold Director $212,536 -$1,576,095 -88% 19 Feb 2026
RA CAPITAL MANAGEMENT, L.P. Director $212,536 +$29,999,985 19 Feb 2026
Glenn Sblendorio Director $212,536 19 Feb 2026
Derek DiRocco Director $212,536 19 Feb 2026
Takeshi Takahashi Director 12 Jul 2023
Alexander Asam Director 09 Feb 2023
Olivier Litzka Director 22 May 2024

Recent Insider Transactions by Companies or Individuals for Mineralys Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
David Malcom Rodman MLYS Common Stock Sale -2.56% $58,270 $26.84 -2,171 82,489 09 Mar 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 2.63% 2,171 84,660 09 Mar 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -8.33% -2,171 23,876 09 Mar 2026 Direct
Ra Capital Management, L.P. MLYS Common Stock Award 6,200 6,200 19 Feb 2026 See footnotes
Ra Capital Management, L.P. MLYS Stock Option (Right to Buy) Award 8,300 8,300 19 Feb 2026 See Footnote
Jon Congleton MLYS Common Stock Award 22% 140,900 780,051 19 Feb 2026 Direct
Jon Congleton MLYS Stock Option Award 187,900 187,900 19 Feb 2026 Direct
Glenn Sblendorio MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Glenn Sblendorio MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
Alexander M. Gold MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Alexander M. Gold MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
Daphne Karydas MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Daphne Karydas MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
Brian Taylor Slingsby MLYS Common Stock Other 0.08% 6,200 7,910,038 19 Feb 2026 See footnote
Brian Taylor Slingsby MLYS Common Stock Other -100% -6,200 0 19 Feb 2026 Direct
Brian Taylor Slingsby MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Brian Taylor Slingsby MLYS Stock Option Other 8,300 8,300 19 Feb 2026 See footnote
Brian Taylor Slingsby MLYS Stock Option Other -100% -8,300 0 19 Feb 2026 Direct
Brian Taylor Slingsby MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
Srinivas Akkaraju MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Srinivas Akkaraju MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
Derek DiRocco MLYS Common Stock Award 6,200 6,200 19 Feb 2026 Direct
Derek DiRocco MLYS Stock Option Award 8,300 8,300 19 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Award 87.1% 38,400 82,489 19 Feb 2026 Direct
David Malcom Rodman MLYS Stock Option Award 51,300 51,300 19 Feb 2026 Direct
Adam Scott Levy MLYS Common Stock Award 461.9% 39,900 48,538 19 Feb 2026 Direct
Adam Scott Levy MLYS Stock Option Award 53,300 53,300 19 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -0.94% $11,505 $27.59 -417 44,089 17 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 0.95% 417 44,506 17 Feb 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -7.15% -417 5,417 17 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -24.2% $385,732 $27.44 -14,055 44,089 13 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 16.4% 7,707 54,603 13 Feb 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -7.16% -7,707 100,001 13 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -11.2% $184,077 $28.99 -6,349 50,437 12 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 12.6% 6,349 56,786 12 Feb 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -16.7% -6,349 31,743 12 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -4.13% $65,586 $30.21 -2,171 50,437 09 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 4.3% 2,171 52,608 09 Feb 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -7.69% -2,171 26,047 09 Feb 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -0.82% $13,354 $32.10 -416 50,437 20 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 0.82% 416 50,853 20 Jan 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -6.66% -416 5,834 20 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -18.4% $370,645 $32.61 -11,367 50,437 14 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -11.1% $252,470 $32.75 -7,709 61,804 13 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 12.5% 7,709 69,513 13 Jan 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -6.89% -7,709 104,167 13 Jan 2026 Direct
Jon Congleton MLYS Common Stock Sale -2.48% $529,640 $32.62 -16,236 639,151 12 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Sale -9.31% $205,143 $32.32 -6,348 61,804 12 Jan 2026 Direct
David Malcom Rodman MLYS Common Stock Options Exercise 10.3% 6,348 68,152 12 Jan 2026 Direct
David Malcom Rodman MLYS Stock Option Options Exercise -14.3% -6,348 38,092 12 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.